Metabolic Homeostasis-Regulated Nanoparticles for Antibody-Independent Cancer Radio-Immunotherapy
© 2022 Wiley-VCH GmbH.
Publié dans: | Advanced materials (Deerfield Beach, Fla.). - 1998. - 34(2022), 51 vom: 26. Dez., Seite e2207343 |
---|---|
Auteur principal: | |
Autres auteurs: | , , , , , , , |
Format: | Article en ligne |
Langue: | English |
Publié: |
2022
|
Accès à la collection: | Advanced materials (Deerfield Beach, Fla.) |
Sujets: | Journal Article abscopal effect autophagy cell metabolism radio-immunotherapy tumor-associated macrophages Liposomes Antibodies |
Résumé: | © 2022 Wiley-VCH GmbH. The special metabolic traits of cancer cells and tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are promising targets for developing novel cancer therapy strategies, especially the glycolysis and mitochondrial energy metabolism. However, therapies targeting a singular metabolic pathway are always counteracted by the metabolic reprogramming of cancer, resulting in unsatisfactory therapeutic effect. Herein, this work employs poly(ethylene glycol)-coated (PEGylated) liposomes as the drug delivery system for both mannose and levamisole hydrochloride to simultaneously inhibit glycolysis and restrain mitochondrial energy metabolism and thus inhibit tumor growth. In combination with radiotherapy, the liposomes can not only modulate the immunosuppressive TME by cellular metabolism regulation to achieve potent therapeutic effect for local tumors, but also suppress the M2 macrophage proliferation triggered by X-ray irradiation and thus enhance the immune response to inhibit metastatic lesions. In brief, this work provides a new therapeutic strategy targeting the special metabolic traits of cancer cells and immunosuppressive TAMs to enhance the abscopal effect of radiotherapy for cancer |
---|---|
Description: | Date Completed 26.12.2022 Date Revised 26.12.2022 published: Print-Electronic Citation Status MEDLINE |
ISSN: | 1521-4095 |
DOI: | 10.1002/adma.202207343 |